Clinical pharmacokinetics of 123I-IAZA in healthy volunteers.

Abstract

123I-labelled iodoazomycin arabinoside (123I-IAZA) is an experimental radiopharmaceutical that has been shown to have clinical utility for imaging regional tissue hypoxia. We report the clinical pharmacokinetics of IAZA, the radiopharmacokinetics of 123I-IAZA and total radioactivity kinetics after injection of 123I-IAZA. Six healthy volunteers each received an intravenous bolus injection of 185 MBq of 123I-IAZA. Thirteen blood samples and a cumulative urine sample were collected over 28 h from each subject. A two-compartment open model best described the disposition characteristics of all three chemical components, with terminal phase half-lives of 179 +/- 24, 232 +/- 41 and 294 +/- 27 min for 123I-IAZA, IAZA and total radioactivity, respectively. 123I-IAZA had a steady-state volume of distribution (Vss) of 0.716 +/- 0.088 l.kg-1 and a systemic clearance (Cls) of 239 +/- 48 ml.min-1. Radioactive decay was responsible for about 37% of clearance; of the remaining radioactivity, about 92% was eliminated renally. Only about 12% of 123I-IAZA was eliminated unchanged in urine, indicating that renal excretion was the major route of elimination for the radioactive metabolites rather than for 123I-IAZA itself. The effective half-lives of 123I-IAZA and total radioactivity reported here are considerably shorter than previously estimated. Our results confirm that 123I-IAZA has appropriate pharmacokinetic and radiopharmacokinetic properties to support clinical hypoxia imaging.

Statistics

020406080'03'05'07'09'11'13'15'17
Citations per Year

75 Citations

Semantic Scholar estimates that this publication has 75 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Stypinski1999ClinicalPO, title={Clinical pharmacokinetics of 123I-IAZA in healthy volunteers.}, author={Daria Stypinski and Leonard Irving Wiebe and Alexander McEwan and Ronald P. Schmidt and Yun Kau Tam and John R. Mercer}, journal={Nuclear medicine communications}, year={1999}, volume={20 6}, pages={559-67} }